Boehringer to cut costs by 15%

Share this article:

Boehringer Ingelheim plans to cut costs by around 15%, which means layoffs. PMLive found the pink-slip item in the German paper Frankfurter Allgemeine Zeitung. The news comes one day after the firm announced disappointing financials for the first half of the year—prescription sales slid 5.4%, to $6.4 billion. The company attributed part of the falloff to deeper discounts required to fit into the post-healthcare-reform marketplace in the US.

PMLive says it is unclear if the layoffs will be distributed throughout the global 45,000-employee workforce or limited to Germany.

Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.